Author

Ana Vega

Brigham and Women's HospitalPrimary ORCID profile (0009-0007-6579-1228 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ana VegaiD1 paper · Marqués de Valdecilla University Hospital

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Assay:GWAS summary statistics· 1 Research Focus:polygenic risk· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Anders Martin DaleiD· 2 shared Azad Razack· 2 shared Cezary CybulskiiD· 2 shared Christiane Maier· 2 shared Eli Marie GrindedaliD· 2 shared Fredrik E. WiklundiD· 2 shared Ian Geoffrey MillsiD· 2 shared Johanna SchleutkeriD· 2 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Anders Martin DaleORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

From a genomic risk model to clinical trial implementation in a learning health system: the ProGRESS Study

Jason L. Vassy, Anna M. Dornisch, Roshan A. Karunamuni, Michael Gatzen, C. Kachulis, Niall J. Lennon, Charles A. Brunette, Morgan E. Danowski, Richard L. Hauger, Isla P. Garraway, Adam Stuart Kibel, Kyung Min Lee, Julie Ann Lynch, Kara N. Maxwell, Brent Shane Rose, , Tyler M. Seibert

The paper develops a polygenic risk model for prostate cancer using VA data and validates it in external cohorts, showing its clinical utility in risk stratification.

medRxiv · Nov 3, 2024 · PreprintGenetic & Genomic Medicine

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

Minh‐Phuong Huynh‐Le, Chun Chieh Fan, Roshan A. Karunamuni, Wesley Kurt Thompson, Marı́a Elena Martı́nez, Rosalind A. Eeles, Zsofia Kote‐Jarai, Kenneth Ross Muir, UKGPCS collaborators, Johanna Schleutker, Nora Pashayan, Jyotsna Batra, APCB (Australian Prostate Cancer BioResource), Henrik Grönberg, David E Neal, , Tyler M. Seibert

This study evaluates a polygenic hazard score in multi-ethnic populations and finds it is associated with age at prostate cancer diagnosis, aggressive diagnosis, and death across European, Asian, and African ancestries.

Nature Communications · Feb 23, 2021Peer-reviewedGenetic & Genomic Medicine